| Literature DB >> 35348851 |
Jingwei Lin1,2,3, Huan Chen1,2, Yudong Bai1,2, Shoukun Li1,2, Gengyuan Liang1,2, Tianning Fan1,2, Ningyuan Gao1,2, Xiupeng Wu1,2, Hui Li1,2, Gang Chen3, Yingxu Gao4, Jungang Fan5.
Abstract
Fungal immunomodulatory protein (FIP) is a novel functional protein family with specific immunomodulatory activity identified from several macro-fungi. A variety of biological activities of FIPs have been reported, such as anti-allergy, anti-tumor, mitogenic activity, and immunomodulation. Among all known FIPs, the firstly discovered FIP was isolated from Ganoderma lucidum, and most FIP members were from Ganoderma genus. Compared with other FIPs, Ganoderma FIPs possess some advantageous bioactivities, like stronger anti-tumor activity. Therein, gene sequences, protein structural features, biofunctions, and recombinant expression of Ganoderma FIPs were summarized and addressed, focusing on elucidating their anti-tumor activity and molecular mechanisms. Combined with current advances, development potential and application of Ganoderma FIPs were also prospected. KEY POINTS: • More than a dozen of reported FIPs are identified from Ganoderma species. • Ganoderma immunomodulatory proteins have superior anti-tumor activity with promising prospects and application. • Current review comprehensively addresses characterization, biofunctions, and anti-tumor mechanisms of Ganoderma FIPs.Entities:
Keywords: Anti-tumor activity; Fungal immunomodulatory protein; Ganoderma; Recombinant expression
Mesh:
Substances:
Year: 2022 PMID: 35348851 DOI: 10.1007/s00253-022-11839-9
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813